Articles for author: Russ Cohen

Russ Cohen

Unleashing Cava Group’s Stock Potential Post Q1 Earnings Surge

In the wake of an impressive Q1 performance, Cava Group CAVA has begun unveiling a growth trajectory that echoes the rise of prominent retail restaurant chains like Chipotle Mexican Grill CMG and Starbucks SBUX. Since its IPO in June of 2023, the Mediterranean fast-casual food chain has witnessed a nearly +100% increase in its stock ...

Russ Cohen

Unusual Options Activity: Advanced Micro Devices, Adobe, Eli Lilly

Advanced Micro Devices (AMD) Today, Advanced Micro Devices Inc (AMD) witnessed remarkable options trading activity, with a total of 649,374 contracts changing hands, equivalent to about 64.9 million underlying shares. This surge represents approximately 127.8% of AMD’s average daily trading volume over the past month. Of particular note was the high volume of the $170 ...

Russ Cohen

Strategies for Stable Profits Amid Market Volatility

The recent surge in the stock market has seen Indexes hitting record highs, driven by Nvidia’s remarkable accomplishment of surpassing the $3 trillion market cap. Expectations of an interest rate cut from the Federal Reserve have added fuel to this bullish trend amidst weaker economic data. In the midst of this market euphoria, tools like ...

Russ Cohen

Viavi Expansion Boosts Network Testing Capabilities Viavi Expansion Boosts Network Testing Capabilities

Viavi Solutions Inc. VIAV has recently disclosed an extended collaboration with Rohde & Schwarz to introduce advanced O-RU testing solutions. This partnership is geared towards supporting the U.S. Department of Commerce’s NTIA Public Wireless Supply Chain Innovation Fund Second Notice of Funding Opportunity. The focus lies on Open Radio Commercialization and Innovation, showcasing commitment to ...

Russ Cohen

Unveiling Significant ETF Inflow – IGM, GOOG, NFLX, QCOM

Exploring Enhancements in ETF Shares Examining changes in shares outstanding among various ETFs, a standout performer is the iShares Expanded Tech Sector ETF (Symbol: IGM), showcasing an approximate $88.0 million dollar inflow – a notable 2.0% increase from the prior week (from 51,150,000 to 52,150,000 units). Within IGM’s key components, trading today reveals Alphabet Inc ...

Russ Cohen

The Revolutionary Energy Charge: 3 Battery Stocks to Watch in June 2024 The Revolutionary Energy Charge: 3 Battery Stocks to Watch in June 2024

Batteries are the backbone of the technology realm, propelling everything from smartphones to electric vehicles. Evolving from standard alkaline cells of yesteryears, lithium-ion batteries now reign as the powerhouse fueling cutting-edge devices globally. The U.S. alone boasts a gargantuan $44.5 billion in the lithium-ion market, anticipating a robust 13.1% Compound Annual Growth Rate (CAGR) over ...

Russ Cohen

Top Picks for Income Investors on June 7th

Financial Stability and Strong Income Yields As the market dances with uncertainty, income investors seek the reliable partners in a volatile dance hall. Shining brightly on today’s stage are three stocks with buy ranks and robust income qualities that tickle the fancies of astute investors on June 7th. First Community Bankshares, Inc.: A Pillar of ...

Russ Cohen

Unveiling the Enigmatic Fortunes of Alibaba Group Holding Limited (BABA)

Decoding Market Interest The current market is abuzz with fervor around Alibaba Group Holding Limited (BABA), sending investors on a hunt for clues into the company’s performance trajectory. Plunging into the depths of investor sentiment, let’s explore the forceful currents driving this e-commerce giant’s stock. Peering into Earnings Roadmap Amidst the turbulent seas of stock ...

Russ Cohen

QIAGEN Announces Discontinuation of NeuMoDx, Updates 2024 Forecast QIAGEN Navigates Exiting NeuMoDx and Adjusting 2024 Outlook

Strategic Shift and Financial Adjustment Sviatlana Zyhmantovich QIAGEN (NYSE:QGEN) shook investors today with the announcement of the discontinuation of its NeuMoDx integrated PCR testing system alongside an update on its 2024 forecast. The medtech company revealed a revised 2024 adjusted diluted EPS projection of at least $2.14 at constant exchange rates (CER), marking an increase ...